Abstract: A controller controls a first inverter drive circuit and a second inverter drive circuit. The first inverter drive circuit drives a load having a load current larger than the second inverter drive circuit. The first inverter drive circuit includes a control ground terminal and a drive ground terminal which are isolated from each other. The ground terminal of the second inverter drive circuit is connected to the ground of the controller. The control ground terminal of the first inverter drive circuit is connected to the ground of the controller. The drive ground terminal of the first inverter drive circuit is connected to the negative side of the first inverter circuit.

Abstract: An electric junction box includes a mounting portion into which an electric component is fitted and mounted. The mounting portion includes a holding wall, a locking hole and a pressing projection. The holding wall surrounds a peripheral surface of the electric component. The locking hole is formed in the holding wall and is locked to a locking projection provided on the peripheral surface of the electric component. The pressing projection protrudes from the holding wall to press and hold the peripheral surface of the electric component. The pressing projection is disposed at a position deviated from a movement path of the locking projection of the electric component to be fitted into the mounting portion.

Abstract: A controller controls a first inverter drive circuit and a second inverter drive circuit. The first inverter drive circuit drives a load having a load current larger than the second inverter drive circuit. The first inverter drive circuit includes a control ground terminal and a drive ground terminal which are isolated from each other. The ground terminal of the second inverter drive circuit is connected to the ground of the controller. The control ground terminal of the first inverter drive circuit is connected to the ground of the controller. The drive ground terminal of the first inverter drive circuit is connected to the negative side of the first inverter circuit.

Abstract: An electric junction box includes a mounting portion into which an electric component is fitted and mounted. The mounting portion includes a holding wall, a locking hole and a pressing projection. The holding wall surrounds a peripheral surface of the electric component. The locking hole is formed in the holding wall and is locked to a locking projection provided on the peripheral surface of the electric component. The pressing projection protrudes from the holding wall to press and hold the peripheral surface of the electric component. The pressing projection is disposed at a position deviated from a movement path of the locking projection of the electric component to be fitted into the mounting portion.

Abstract: An electric connection box includes a pair of second slits having a pair of first slits interposed therebetween in an aligning direction, penetrating a wall portion in a facing direction, extending from an insertion hole to a supporting portion side along an insertion direction, having respective front ends that are closed ends on the supporting portion side, and overlapping with the first slits in the aligning direction.

Abstract: A stator includes a first teeth unit including a first insulator having an annular first crossover wire guide and a plurality of first winding units radially provided at regular intervals on an outer circumference of the first crossover wire guide to cover teeth of one phase group of an alternating current, the teeth of the one phase group having upper halves fitted to the first winding units, a third insulator that covers lower halves of the teeth, and a winding wire of one phase wound around the teeth of the one phase group, a second teeth unit having an identical configuration to that of the first teeth unit in which a winding wire of the other phase is wound in a concentrated manner, with second winding units inserted between adjacent ones of the first winding units, and an annular yoke including a plurality of recesses at regular intervals.

Abstract: There is provided a connector including a terminal which is provided with an electrical connection section with a tab shape that is provided with a raised part which extends along a terminal fitting direction, and a connector housing which is provided with a terminal accommodating chamber that accommodates the terminal, and an insertion hole through which the electrical connection section is inserted in the terminal accommodating chamber and protrudes outward.

Abstract: There is provided a connector including a terminal which is provided with an electrical connection section with a tab shape that is provided with a raised part which extends along a terminal fitting direction, and a connector housing which is provided with a terminal accommodating chamber that accommodates the terminal, and an insertion hole through which the electrical connection section is inserted in the terminal accommodating chamber and protrudes outward.

Abstract: A stator includes a first teeth unit including a first insulator having an annular first crossover wire guide and a plurality of first winding units radially provided at regular intervals on an outer circumference of the first crossover wire guide to cover teeth of one phase group of an alternating current, the teeth of the one phase group having upper halves fitted to the first winding units, a third insulator that covers lower halves of the teeth, and a winding wire of one phase wound around the teeth of the one phase group, a second teeth unit having an identical configuration to that of the first teeth unit in which a winding wire of the other phase is wound in a concentrated manner, with second winding units inserted between adjacent ones of the first winding units, and an annular yoke including a plurality of recesses at regular intervals.

Abstract: Measurement reference lengths of length and width are set with respect to a convex structure, and an average of vertical distances between tip points and bottom points inside a measurement reference area is calculated as an average height. An average of horizontal distances between the tip points and bottom points is calculated as an average distance. A value obtained by dividing the average height by the average distance provides a gradient ratio. An inverse tangent of the gradient ratio provides an average gradient angle. When the average gradient angle ranges from 5 degrees to 15 degrees and a standard deviation of average gradient angle ranges from 30% to 40% of the average gradient angle, a regular reflectance at a regular reflection angle with respect to incident light of an angle of 30 degrees from a normal direction of the film surface is 1% or less.

Abstract: The present invention provides a compound represented by the following formula (I) or a physiologically acceptable salt thereof, and use thereof for the prophylaxis or treatment of TGF-?-related diseases: wherein Y is a hydrogen atom and the like; R2 is and the like; R3 is —NR8—R9— and the like; R4, R5, R6 and R7 are the same or different and each is a hydrogen atom and the like; and X is and the like.

Abstract: The present invention provides a metastin derivative represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a pharmaceutical composition containing it. The metastin derivative or a salt thereof is superior in blood stability, and has a cancer metastasis suppressive action or cancer growth suppressive action.

Abstract: The present invention provides a compound represented by the following formula (I) or a physiologically acceptable salt thereof, and use thereof for the prophylaxis or treatment of TGF-?-related diseases: wherein Y is a hydrogen atom and the like; R2 is and the like; R3 is —NR8—R9— and the like; R4, R5, R6 and R7 are the same or different and each is a hydrogen atom and the like; and X is and the like.

Abstract: The present invention provides a compound represented by the following formula (1); wherein R1 is an aryl group etc.; R2 is —CO—NH— etc.; R3 is a methyl group having an aromatic group or a cycloalkyl group; R4 is a hydrogen atom etc.; R5 is a methyl group having an aromatic group; and R6 is an amino group or an N-alkyl substituted amino group, having a low-molecular weight and a superior GPR54 agonist activity, and a pharmaceutical composition containing the compound.

Abstract: Measurement reference lengths of length and width are set with respect to a convex structure, and an average of vertical distances between tip points and bottom points inside a measurement reference area is calculated as an average height. An average of horizontal distances between the tip points and bottom points is calculated as an average distance. A value obtained by dividing the average height by the average distance provides a gradient ratio. An inverse tangent of the gradient ratio provides an average gradient angle. When the average gradient angle ranges from 5 degrees to 15 degrees and a standard deviation of average gradient angle ranges from 30% to 40% of the average gradient angle, a regular reflectance at a regular reflection angle with respect to incident light of an angle of 30 degrees from a normal direction of the film surface is 1% or less.

Abstract: The present invention provides a metastin derivative represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, or a pharmaceutical composition containing it. The metastin derivative or a salt thereof is superior in blood stability, and has a cancer metastasis suppressive action or cancer growth suppressive action.

Abstract: The present invention relates to the production of an N36-binding peptide at low cost and in a large quantity utilizing a microorganism. More specifically, the present invention relates to a method for producing an N36-binding peptide comprising introducing a recombinant vector into which a DNA molecule encoding an N36-binding peptide that binds to an N36 protein derived from a retrovirus that causes immunodeficiency in a mammal has been incorporated into E. coli as a host to produce a transformant.

Abstract: The present invention provides a compound represented by the following formula (1); wherein R1 is an aryl group etc.; R2 is —CO—NH— etc.; R3 is a methyl group having an aromatic group or a cycloalkyl group; R4 is a hydrogen atom etc.; R5 is a methyl group having an aromatic group; and R6 is an amino group or an N-alkyl substituted amino group, having a low-molecular weight and a superior GPR54 agonist activity, and a pharmaceutical composition containing the compound.

Abstract: Disclosed are compounds for inhibiting the binding of an SH2 domain-containing protein, for example, a compound of formula (I): FORMULA (I) wherein R1 is a lipophile; R2, in combination with the phenyl ring, is a phenylphosphate mimic group or a protected phenylphosphate mimic group; R3 is, for example, hydrogen, azido, amino, oxalylamino, carboxy alkyl, alkoxycarbonyl alkyl, aminocarbonyl alkyl, or alkyl carbonylamino; R6 is a linker; AA is an amino acid; and n is 1 to 6; or a pharmaceutically acceptable salt, stereoisomer, solvate, or hydrate thereof. Also disclosed are pharmaceutical compositions and methods of use of such compounds.

Abstract: The invention relates to metastin derivatives represented by the formula: X-AA1-AA2-AA3-AA4-Z (I), or a salt thereof, or a pro-drug thereof, which have cancer metastatis suppressing activity and cancer proliferation suppressing activity. The invention also relates to the use of these derivatives as drugs for preventing or treating cancers.